Search

Search Funnelback University

Search powered by Funnelback
Your query has been expanded to `News and Events` |u:www.enterprize.cam.ac.uk.  Search for `News and Events` |u:www.enterprise.cam.ac.uk instead.
31 - 40 of 60 search results for `News and Events` |u:www.enterprise.cam.ac.uk or `News and Events` |u:www.enterprize.cam.ac.uk
  1. Fully-matching results

  2. Sentinel Oncology awarded Eurostars grant for research and

    https://www.enterprise.cam.ac.uk/news/sentinel-oncology-awarded-eurostars-grant-for-rd/
    Thumbnail for Sentinel Oncology awarded Eurostars grant for research and development – Cambridge Enterprise 23 Oct 2020: Current drug treatments for AML suffer from poor efficacy and numerous unwanted side-effects. ... The Eurostars programme was established to assist small and medium enterprises (SMEs) in obtaining research and development funding.
  3. disease Archives – Cambridge Enterprise

    https://www.enterprise.cam.ac.uk/tag/disease/feed/
    26 Jul 2024: camenterprise.dev.twkmedia.com/?post_type=news&p=11819 pFluidic Analytics Ltd, a Cambridge Enterprise portfolio company, has raised $31 million to continue developing its transformational products for characterising proteins ... 342px) 100vw, 342px"
  4. Cambridge and Nanjing launch strategic collaboration – Cambridge…

    https://www.enterprise.cam.ac.uk/news/cambridge-and-nanjing-launch-strategic-collaboration/
    Thumbnail for Cambridge and Nanjing launch strategic collaboration – Cambridge Enterprise 23 Oct 2020: As well as supporting health and wellbeing in new cities, the new Centre will help deliver efficient energy use through its academic and entrepreneurial activities. ... The Vice-Chancellor was joined by Professor Sir Mark Welland, Head of the
  5. Annual awards recognise Cambridge innovation and excellence –…

    https://www.enterprise.cam.ac.uk/news/annual-awards-recognise-cambridge-innovation-and-excellence/
    Thumbnail for Annual awards recognise Cambridge innovation and excellence – Cambridge Enterprise 23 Feb 2023: million Series A Funding with Medicxi and Johnson & Johnson Innovation to develop antibodies with anticoagulant properties. ... into the discovery of first-in-class drugs in oncology and other diseases.
  6. protein social network Archives – Cambridge Enterprise

    https://www.enterprise.cam.ac.uk/tag/protein-social-network/feed/
    26 Jul 2024: camenterprise.dev.twkmedia.com/?post_type=news&p=11819 pFluidic Analytics Ltd, a Cambridge Enterprise portfolio company, has raised $31 million to continue developing its transformational products for characterising proteins ... 342px) 100vw, 342px"
  7. Academy award for founder and CEO of Cambridge spin-out – Cambridge…

    https://www.enterprise.cam.ac.uk/news/academy-award-for-founder-and-ceo-of-cambridge-spin-out/
    Thumbnail for Academy award for founder and CEO of Cambridge spin-out – Cambridge Enterprise 22 Feb 2023: 10 July 2019. Academy award for founder and CEO of Cambridge spin-out. ... in applications ranging from power supplies for consumer electronics to LED drives, data centres and wireless chargers.
  8. A look at golden shares and anti-dilution provisions – Cambridge…

    https://www.enterprise.cam.ac.uk/news/a-look-at-golden-shares-and-anti-dilution-provisions/
    Thumbnail for A look at golden shares and anti-dilution provisions – Cambridge Enterprise 23 Oct 2020: Hockaday, CEO, Isis Innovation ltd and Tony Hickson, Managing Director Technology Transfer, Imperial Innovations plc. ... that UK universities take too much equity in spin-outs and more equity should be retained by founding entrepreneurs to incentivise
  9. Spin-out Morphogen-IX announces appointment of CEO and SAB members –…

    https://www.enterprise.cam.ac.uk/news/spin-morphogen-ix-announces-appointment-ceo-sab-members/
    Thumbnail for Spin-out Morphogen-IX announces appointment of CEO and SAB members – Cambridge Enterprise 23 Oct 2020: 28 June 2018. Spin-out Morphogen-IX announces appointment of CEO and SAB members. ... The SAB comprises leading international experts in the field of PAH research, experimental medicine and clinical trials:.
  10. Biomarker signature identified for Crohn's and ulcerative colitis …

    https://www.enterprise.cam.ac.uk/news/biomarker-signature-identified-for-crohns-and-ulcerative-colitis/
    Thumbnail for Biomarker signature identified for Crohn's and ulcerative colitis – Cambridge Enterprise 23 Oct 2020: Share:. Crohn’s disease and ulcerative colitis are increasingly common, chronic forms of inflammatory bowel disease which predominantly affect young adults. ... Cambridge Enterprise, the University’s commercialisation group, is seeking a commercial
  11. Cambridge Graphene Centre and Plastic Logic announce partnership –…

    https://www.enterprise.cam.ac.uk/news/cambridge-graphene-centre-and-plastic-logic-announce-partnership/
    Thumbnail for Cambridge Graphene Centre and Plastic Logic announce partnership – Cambridge Enterprise 23 Oct 2020: Share:. A formal collaboration between Cambridge’s Graphene Centre, and the University spin-out company, Plastic Logic, has been announced. ... The research of the Centre aims to find ways of manufacturing and optimising graphene and related materials

Search history

Recently clicked results

Recently clicked results

Your click history is empty.

Recent searches

Recent searches

Your search history is empty.